These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7475881)

  • 21. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
    Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
    Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A study on the state of cell proliferation and apoptosis in human middle ear cholesteatoma].
    Yu Q; Jin K
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):450-1. PubMed ID: 12541689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of vascular morphology with clinical types in cholesteatoma of the middle ear.
    Stammberger M; Bujía J; Schulz P
    Am J Otol; 1994 May; 15(3):380-2. PubMed ID: 8579144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoclast stimulating and differentiating factors in human cholesteatoma.
    Hamzei M; Ventriglia G; Hagnia M; Antonopolous A; Bernal-Sprekelsen M; Dazert S; Hildmann H; Sudhoff H
    Laryngoscope; 2003 Mar; 113(3):436-42. PubMed ID: 12616193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.
    Bujia J; Sudhoff H; Holly A; Hildmann H; Kastenbauer E
    Eur Arch Otorhinolaryngol; 1996; 253(1-2):21-4. PubMed ID: 8932424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retraction theory and proliferation theory.
    Sudhoff H; Tos M
    Am J Otol; 2000 Nov; 21(6):786-92. PubMed ID: 11078064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Argyrophilic nucleolar organizer regions in auditory meatal skin and middle ear cholesteatoma.
    Sudhoff H; Fisseler-Eckhoff A; Stark T; Borkowski G; Luckhaupt H; Cooper J; Michaels L
    Clin Otolaryngol Allied Sci; 1997 Dec; 22(6):545-8. PubMed ID: 9466068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma.
    Bujía J; Holly A; Schilling V; Negri B; Pitzke P; Schulz P
    Laryngoscope; 1993 Mar; 103(3):326-9. PubMed ID: 7680089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
    Shinoda H; Huang CC
    Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Markers of epidermal proliferation in middle ear cholesteatoma].
    Hassmann-Poznańska E; Skotnicka B; Dziecioł J
    Otolaryngol Pol; 2003; 57(4):505-11. PubMed ID: 14587387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Air-exposed tissue culture of human middle ear epithelium and meatal epidermis: a method to study the advancing front of cholesteatoma.
    Albers-op t' Hof BM; Peek FA; Huisman MA; Grote JJ
    Acta Otolaryngol; 2002 Oct; 122(7):720-5. PubMed ID: 12484648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
    Holly A; Sittinger M; Bujia J
    Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
    Kuczkowski J; Pawelczyk T; Bakowska A; Narozny W; Mikaszewski B
    Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stromal expression of matrix metalloprotease-9 in middle ear cholesteatomas.
    Shibosawa E; Tsutsumi K; Takakuwa T; Takahashi S
    Am J Otol; 2000 Sep; 21(5):621-4. PubMed ID: 10993447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications.
    Albino AP; Reed JA; Bogdany JK; Sassoon J; Desloge RB; Parisier SC
    Am J Otol; 1998 Jan; 19(1):30-6. PubMed ID: 9455944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope.
    Key G; Becker MH; Baron B; Duchrow M; Schlüter C; Flad HD; Gerdes J
    Lab Invest; 1993 Jun; 68(6):629-36. PubMed ID: 7685843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
    Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
    Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
    Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
    Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
    Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
    Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
    Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.